ENZON PHARMACEUTICALS, INC.
ENZNNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for ENZN. That does not mean none is planned.
Get an email about ENZN's next catalysts
Track ENZON PHARMACEUTICALS (ENZN) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 0 past
No catalysts found.
Market Overview
Stock performance and key metrics
Enzon Pharmaceuticals, Inc. is a pharmaceutical company. Its headquarters is in Piscataway, New Jersey. The company is a publicly traded company on NASDAQ under the symbol "ENZN". It's also doing marketing works in Asia areas such as China. In 2012, the company orally presented in Nanjing, China about the symposium of its drug delivery systems, which help improve therapeutic molecules' pharmaceutical properties.
WebsitePrednisone, Vincristine, Daunorubicin, PEG-L-asparaginase, Erwinia L-asparaginase, Doxorubicin, Cyclophosphamide, Cytarabine, Thioguanine
Acute Lymphoblastic Leukemia
ABLC
Invasive Fungal Infections
Clofarabine, Methotrexate, Mercaptopurine, Dexamethasone, Etoposide, Dasatinib
Acute Lymphoblastic Leukemia
Posaconazole
Invasive Fungal Infections
6 Mercaptopurine
Acute Lymphoblastic Leukemia
Cyclophosphamide (CTX)
Acute Lymphoblastic Leukemia
Decadron
Acute Lymphoblastic Leukemia
PEG-asparaginase
Acute Lymphoblastic Leukemia
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Prednisone, Vincristine, Daunorubicin, PEG-L-asparaginase, Erwinia L-asparaginase, Doxorubicin, Cyclophosphamide, Cytarabine, Thioguanine | Phase 3 | Acute Lymphoblastic Leukemia | - | - |
ABLC | Phase 3 | Invasive Fungal Infections | - | - |
Clofarabine, Methotrexate, Mercaptopurine, Dexamethasone, Etoposide, Dasatinib | Phase 3 | Acute Lymphoblastic Leukemia | - | - |
Posaconazole | Phase 3 | Invasive Fungal Infections | - | - |
6 Mercaptopurine | Phase 2 | Acute Lymphoblastic Leukemia | - | - |
Cyclophosphamide (CTX) | Phase 2 | Acute Lymphoblastic Leukemia | - | - |
Decadron | Phase 2 | Acute Lymphoblastic Leukemia | - | - |
PEG-asparaginase | Phase 2 | Acute Lymphoblastic Leukemia | - | - |
Frequently asked questions
What is in ENZON PHARMACEUTICALS, INC.'s drug pipeline?β
CatalystAlert tracks 8 drug candidates in ENZON PHARMACEUTICALS, INC.'s (ENZN) pipeline across Phase 3, Phase 2. Its lead program is ABLC (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is ENZON PHARMACEUTICALS, INC.'s next FDA catalyst?β
CatalystAlert tracks every upcoming catalyst for ENZON PHARMACEUTICALS, INC. (ENZN) β PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β each confidence-rated as confirmed, estimated or AI-detected.
How do I track ENZN biotech catalysts?β
Add ENZN to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow ENZON PHARMACEUTICALS, INC.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β sourced from ClinicalTrials.gov, FDA and SEC filings.
